Free Trial

Sherbrooke Park Advisers LLC Invests $765,000 in The Cooper Companies, Inc. (NASDAQ:COO)

Cooper Companies logo with Medical background

Sherbrooke Park Advisers LLC acquired a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 8,318 shares of the medical device company's stock, valued at approximately $765,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in COO. Byrne Asset Management LLC bought a new position in shares of Cooper Companies during the 4th quarter worth about $33,000. OFI Invest Asset Management bought a new position in shares of Cooper Companies during the 4th quarter worth about $34,000. New Age Alpha Advisors LLC bought a new position in shares of Cooper Companies during the 4th quarter worth about $38,000. Covestor Ltd lifted its position in Cooper Companies by 35.5% in the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company's stock valued at $42,000 after acquiring an additional 120 shares in the last quarter. Finally, Atala Financial Inc bought a new position in Cooper Companies in the 4th quarter valued at about $51,000. Institutional investors own 24.39% of the company's stock.

Cooper Companies Price Performance

Cooper Companies stock opened at $82.92 on Friday. The Cooper Companies, Inc. has a 52 week low of $69.81 and a 52 week high of $112.38. The company's 50 day moving average price is $80.19 and its two-hundred day moving average price is $90.20. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The stock has a market cap of $16.58 billion, a P/E ratio of 42.52, a P/E/G ratio of 2.25 and a beta of 1.08.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, hitting the consensus estimate of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The firm had revenue of $964.70 million for the quarter, compared to analysts' expectations of $981.25 million. On average, equities analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analyst Ratings Changes

Several equities analysts recently weighed in on the stock. Robert W. Baird dropped their price target on shares of Cooper Companies from $117.00 to $107.00 and set an "outperform" rating on the stock in a research report on Friday, March 7th. JPMorgan Chase & Co. dropped their price target on shares of Cooper Companies from $120.00 to $110.00 and set an "overweight" rating on the stock in a research report on Friday, March 7th. Citigroup dropped their price target on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a research report on Friday, March 7th. Piper Sandler reaffirmed an "overweight" rating and issued a $115.00 price target (down previously from $120.00) on shares of Cooper Companies in a research report on Friday, March 7th. Finally, Stifel Nicolaus dropped their price target on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating on the stock in a research report on Friday, March 7th. Four investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $110.25.

Check Out Our Latest Stock Analysis on COO

Cooper Companies Profile

(Free Report)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Featured Stories

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO - Free Report).

Institutional Ownership by Quarter for Cooper Companies (NASDAQ:COO)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cooper Companies Right Now?

Before you consider Cooper Companies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cooper Companies wasn't on the list.

While Cooper Companies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

4 Biotech Stocks on the Verge of Massive Breakthroughs
New AI Deals Just Sent These 4 Infrastructure Stocks Soaring
7 Nuclear Stocks One Announcement Away from Exploding

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines